Publications by authors named "Brenna R Hedin"

Two factors known to contribute to the development of myelodysplastic syndrome (MDS) and other blood cancers are (i) somatically acquired mutations in components of the spliceosome and (ii) increased inflammation. Spliceosome genes, including SF3B1, are mutated at high frequency in MDS and other blood cancers; these mutations are thought to be neomorphic or gain-of-function mutations that drive disease pathogenesis. Likewise, increased inflammation is thought to contribute to MDS pathogenesis; inflammatory cytokines are strongly elevated in these patients, with higher levels correlating with worsened patient outcome.

View Article and Find Full Text PDF

Alveolar macrophages serve as central orchestrators of inflammatory responses in the lungs, both initiating their onset and promoting their resolution. However, the mechanisms that program macrophages for these dynamic responses are not fully understood. Over 95% of all mammalian genes undergo alternative pre-mRNA splicing.

View Article and Find Full Text PDF

Myelodysplastic syndrome (MDS) is a malignant hematopoietic stem cell disorder that frequently evolves into acute myeloid leukemia (AML). Patients with MDS are prone to infectious complications, in part due to the presence of severe neutropenia and/or neutrophil dysfunction. However, not all patients with neutropenia become infected, suggesting that other immune cells may compensate in these patients.

View Article and Find Full Text PDF

Secretory cells produce diverse cargoes, yet how they regulate concomitant secretory traffic remains insufficiently explored. Rab GTPases control intracellular vesicular transport. To map secretion pathways, we generated a library of lentivirus-expressed dominant-negative Rab mutants and used it in a large-scale screen to identify regulators of hepatic lipoprotein secretion.

View Article and Find Full Text PDF
Article Synopsis
  • Acute respiratory distress syndrome (ARDS) involves significant inflammation, with Toll-like receptor (TLR) signaling playing a dual role in fighting infection and contributing to harmful inflammation.
  • Researchers studied the alternative splicing of TLR-related genes (MyD88 and IRAK1) in patients with ARDS and discovered a shift towards pro-inflammatory mRNA types in their immune cells compared to healthy individuals.
  • The altered levels of a specific anti-inflammatory isoform (IRAK1c) in ARDS patients were linked to survival outcomes, indicating that understanding these splicing changes could inform new treatment strategies for ARDS.
View Article and Find Full Text PDF